GF SEC (01776) has been authorized to issue corporate bonds not exceeding 70 billion yuan.

20:25 22/01/2026

Guangfa Securities (01776) announced that recently, the company has received the approval from the China Securities Regulatory Commission for the registration of Guangfa Securities Co., Ltd. to publicly issue corporate bonds to professional investors (Approval No. [2026] 100). The main content of the approval is as follows: to approve the company's registration application to publicly issue corporate bonds with a total face value not exceeding 70 billion yuan to professional investors.

GF SEC (01776) announced that the company has recently received approval from the China Securities Regulatory Commission for the registration of the company's public issuance of corporate bonds to professional investors. The approval allows the company to publicly issue corporate bonds with a total face value not exceeding 70 billion yuan.

LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.

LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.

MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.

LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.

LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.

MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.